← Open Payments lookup

LEAH MULDOON: Open Payments

NPI 1275145047 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$628 in 27 payments from 11 companies in 2025. Trend: 2023 $747 · 2024 $776 · 2025 $628

Food & beverage: $628
CompanyPaymentsAmount
Madrigal Pharmaceuticals5$153
Takeda Pharmaceuticals U.S.A., Inc.4$97
Regeneron Healthcare Solutions, Inc.4$89
Janssen Biotech, Inc.3$68
Ipsen Biopharmaceuticals, Inc2$55
ABBVIE INC.3$51
Aimmune Therapeutics, Inc.1$26
Phathom Pharmaceuticals, Inc.2$25
GENZYME CORPORATION1$24
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$22

Products named: REZDIFFRA, DUPIXENT, ENTYVIO, TREMFYA, RINVOQ, IQIRVO, ZENPEP, VOQUEZNA.

Industry payments across ID — which companies pay providers there.